This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Onel, K. Articles by Onel, K Search for Related Content PubMed PubMed Citation Articles by Onel, K. Articles by Onel, K Social Bookmarking                         What's this?

Lack of Association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults

Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA konel{at}uchicago.edu

D Huo

Department of Health Studies, University of Chicago, Chicago, IL 60637, USA

D Hastings

Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA

J Fryer-Biggs

Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA

MK Crow

Department of Rheumatology, Hospital for Special Surgery, New York, NY 10021, USA

K Onel

Department of Pediatrics, University of Chicago, Chicago, IL 60637, USA; University of Chicago Cancer Research Centre, University of Chicago, Chicago, IL, USA konel{at}uchicago.edu

The p53 tumour suppressor is the central regulator of apoptosis. Previously, the functional TP53 Arg72Pro polymorphism was found to be associated with systemic lupus erythematosus (SLE) in Koreans but not Spaniards. MDM2 is the major negative regulator of p53. An intronic polymorphism in MDM2, the SNP309, attenuates p53 activity and is associated with accelerated tumour development in premenopausal women. Polymorphic variation in MDM2 has never been studied in SLE. The aim of this study is to further assess the contribution of p53-pathway genetic variation to SLE by testing the association of the TP53 Arg72Pro polymorphism and the MDM2 SNP309 with SLE in a well-characterised and ethnically diverse cohort of patients with both childhood- and adult-onset SLE (n = 314). No association was found between the TP53 Arg72Pro polymorphism and SLE in patients of European descent, Asian descent or in African Americans, nor was an association found between the MDM2 SNP309 and SLE in patients of European descent or in African Americans. In addition, there was no correlation between either variant and early-onset disease or nephritis, an index of severe disease. It is concluded that neither the TP53 Arg72Pro polymorphism nor the MDM2 SNP309 contributes significantly to either susceptibility or disease severity in SLE.

Key Words: genetic polymorphism • nephritis • pediatrics • systemic lupus erythematosus

Lupus, Vol. 18, No. 1, 61-66 (2009)
DOI: 10.1177/0961203308094558


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?